Treatment outcome of high-dose image-guided intensity-modulated radiotherapy using intra-prostate fiducial markers for localized prostate cancer at a single institute in Japan

Table 4 Literature review

	RT dose (Gy)		ADT rate (%)	ADT duration (M)	PSA relapse-free survival (%)
Alicikus et al.[1]	81	LR	54 (total)	3	PD: 10-year	81
		IR				78
		HR				62
Martin et al.[4]	79.8	LR	13.6	not mentioned	PD: 5-year	88.4
		IR	11.0			76.5
		HR	45.9			77.9
Zelefsky et al.[12]	81	LR	33.5	3	AD: 8-year	85
		IR	52			76
		HR	92			72
		LR	33.5		PD: 8-year	89
		IR	52			78
		HR	92			67
Cahlon, et al.[16]	86.4	LR	66 (total)	3 or 9	PD: 5-year	98
		IR				85
		HR				70
Current study	80 or 76	IR	67	5 (median) (range: 4–32)	PD: 5-year	100
		HR	95	12 (median) (range: 2–88)		82.2

Abbreviations: RT, radiotherapy; M, months; LR, low risk; PD, Phoenix Consensus definition; AD, American Society for Therapeutic Radiology and Oncology definition; other abbreviations as in Table1.

ISSN: 1748-717X